Truist Financial Maintains Medpace(MEDP.US) With Hold Rating, Maintains Target Price $415
Truist Financial Initiates Medpace(MEDP.US) With Hold Rating, Announces Target Price $415
Medpace Hldgs Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Medpace Holdings (MEDP) and Roche Holding AG (OtherRHHVF)
Medpace Holdings Price Target Cut to $336.00/Share From $395.00 by Deutsche Bank
A Quick Look at Today's Ratings for Medpace(MEDP.US), With a Forecast Between $430 to $480
Deutsche Bank Adjusts Medpace Holdings Price Target to $336 From $395, Maintains Hold Rating
Medpace Holdings: Caution Ahead Despite Strong Performance – Hold Rating Justified
Medpace Hldgs Analyst Ratings
TD Cowen Maintains Medpace(MEDP.US) With Buy Rating, Maintains Target Price $452
TD Cowen Remains a Buy on Medpace Holdings (MEDP)
Baird Adjusts Medpace Holdings' Price Target to $469 From $456, Keeps Outperform Rating
Medpace Hldgs Analyst Ratings
Medpace Hldgs Analyst Ratings
Medpace Holdings (MEDP) Receives a New Rating From TD Cowen
Medpace Hldgs Analyst Ratings
Medpace Holdings (MEDP): A Strong Buy on Robust Organic Growth and Financial Stability
Medpace Hldgs Analyst Ratings
Medpace Hldgs Analyst Ratings
Medpace Hldgs Analyst Ratings